BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zannella C, Rinaldi L, Boccia G, Chianese A, Sasso FC, De Caro F, Franci G, Galdiero M. Regulation of m6A Methylation as a New Therapeutic Option against COVID-19. Pharmaceuticals (Basel) 2021;14:1135. [PMID: 34832917 DOI: 10.3390/ph14111135] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Horlacher M, Oleshko S, Hu Y, Ghanbari M, Cantini G, Schinke P, Vergara EE, Bittner F, Mueller NS, Ohler U, Moyon L, Marsico A. A computational map of the human-SARS-CoV-2 protein-RNA interactome predicted at single-nucleotide resolution. NAR Genom Bioinform 2023;5:lqad010. [PMID: 36814457 DOI: 10.1093/nargab/lqad010] [Reference Citation Analysis]
2 Ntemafack A, Singh RV, Ali S, Kuiate JR, Hassan QP. Antiviral potential of anthraquinones from Polygonaceae, Rubiaceae and Asphodelaceae: potent candidates in the treatment of SARS-COVID-19, A comprehensive review. S Afr J Bot 2022. [PMID: 36193345 DOI: 10.1016/j.sajb.2022.09.043] [Reference Citation Analysis]
3 Wang Z, Belecciu T, Eaves J, Reimers M, Bachmann MH, Woldring D. Phytochemical drug discovery for COVID-19 using high-resolution computational docking and machine learning assisted binder prediction. J Biomol Struct Dyn 2022;:1-21. [PMID: 35993534 DOI: 10.1080/07391102.2022.2112976] [Reference Citation Analysis]
4 Alvarado-marchena L, Martínez-pérez M, Úbeda JR, Pallas V, Aparicio F. Impact of the Potential m6A Modification Sites at the 3′UTR of Alfalfa Mosaic Virus RNA3 in the Viral Infection. Viruses 2022;14:1718. [DOI: 10.3390/v14081718] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Song N, Cui K, Zhang K, Yang J, Liu J, Miao Z, Zhao F, Meng H, Chen L, Chen C, Li Y, Shao M, Zhang J, Wang H. The Role of m6A RNA Methylation in Cancer: Implication for Nature Products Anti-Cancer Research. Front Pharmacol 2022;13:933332. [DOI: 10.3389/fphar.2022.933332] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Ting CT, Chen BS. Repurposing Multiple-Molecule Drugs for COVID-19-Associated Acute Respiratory Distress Syndrome and Non-Viral Acute Respiratory Distress Syndrome via a Systems Biology Approach and a DNN-DTI Model Based on Five Drug Design Specifications. Int J Mol Sci 2022;23:3649. [PMID: 35409008 DOI: 10.3390/ijms23073649] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Horlacher M, Oleshko S, Hu Y, Ghanbari M, Cantini G, Schinke P, Vergara EE, Bittner F, Mueller NS, Ohler U, Moyon L, Marsico A. Computational Mapping of the Human-SARS-CoV-2 Protein-RNA Interactome.. [DOI: 10.1101/2021.12.22.472458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]